Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[finesand]

Little Chart Update Again (lowest RSI ever)

- Priced below Consensi Approval & NT219 Ownership
- Priced at FDA refuted Consensi data falsification allegations on July'17
- Lowest RSI ever (oversold)
- Consensi: $2.40/sh for China + Korea
- Consensi: $3.94/sh for US + CA -> $6.79/sh Total
- Changshan paid $1M (May'18) and will pay additional $2.5M for short CFDA regulatory and up to $6M for commercial milestones
- Changshan in CFDA process, which is a formality having FDA approval lately
- Changshan & Korea 12% Net Royalties, same expected for US
- Awaiting deal with US pharma
- 2018-06-01 Annual offering 3.26M @ $2.50/ads (still)
- 2018-06-19 HC Wainwright last Buy PT $12.50/sh

(SeaOfSand and I keep tracking, should bounce)

Daily


Evaluation (nothing changes)